You have 9 free searches left this month | for more free features.

Burkitt Lymphoma

Showing 4626 - 4650 of 5,429

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma Trial in Shanghai (nucleoside analog reverse transcriptase inhibitor)

Unknown status
  • Lymphoma
  • nucleoside analog reverse transcriptase inhibitor
  • Shanghai, Shanghai, China
  • +1 more
Jan 7, 2014

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Zion (carboplatin, docetaxel, ifosfamide)

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • Zion, Illinois
    Midwestern Regional Medical Center
Mar 25, 2013

Osteonecroses in Pediatric Patients With ALL

Unknown status
  • Osteonecrosis
  • +2 more
    • Aachen, Germany
    • +24 more
    Mar 4, 2014

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Withdrawn
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +102 more
    • management of therapy complications
    • musculoskeletal complications management/prevention
    • (no location specified)
    Jul 5, 2012

    Immunosuppression Trial in Atlanta (Flu Vaccine)

    Completed
    • Immunosuppression
    • Flu Vaccine
    • Atlanta, Georgia
    • +1 more
    Jun 19, 2014

    Malignant Solid Tumor, Lymphomas, Multiple Myeloma Trial in Scottsdale, Columbus, San Antonio (AV-299, AV-299 + erlotinib)

    Completed
    • Malignant Solid Tumor
    • +2 more
    • AV-299
    • AV-299 + erlotinib
    • Scottsdale, Arizona
    • +2 more
    Jan 23, 2014

    Lymphoma Follow-up

    Completed
    • Lymphoma
      • Baltimore, Maryland
        NIA Clinical Research Unit
      Dec 19, 2013

      Esophageal Cancer, Lung Cancer, Lymphoma Trial in Madison (topotecan HCl, low-LET electron therapy, low-LET photon therapy)

      Completed
      • Esophageal Cancer
      • +2 more
      • topotecan hydrochloride
      • +2 more
      • Madison, Wisconsin
        University of Wisconsin Comprehensive Cancer Center
      Feb 8, 2013

      Hematologic Malignancies, Multiple Myeloma, Lymphoma Trial in Atlanta, Buffalo (MLN4924)

      Completed
      • Hematologic Malignancies
      • +3 more
      • Atlanta, Georgia
      • +1 more
      Nov 15, 2013

      Lymphoma, Solid Tumor Trial in Baltimore (chemo, oral sodium phenylbutyrate)

      Completed
      • Lymphoma
      • Unspecified Adult Solid Tumor, Protocol Specific
      • Baltimore, Maryland
        Johns Hopkins Oncology Center
      Feb 4, 2013

      Lymphoma Trial in Japan (Fludarabine Phosphate (Fludara))

      Completed
      • Lymphoma
      • Fludarabine Phosphate (Fludara)
      • Nagoya-shi, Aichi, Japan
      • +16 more
      Dec 2, 2013

      Lymphoma Trial in Cleveland (iodine I 131 mAb Lym-1)

      Completed
      • Lymphoma
      • iodine I 131 monoclonal antibody Lym-1
      • Cleveland, Ohio
        Ireland Cancer Center
      Jan 8, 2014

      Lymphoma Trial in East Melbourne, Plymouth (rituximab, cyclophosphamide, fludarabine phosphate)

      Completed
      • Lymphoma
      • rituximab
      • +2 more
      • East Melbourne, Victoria, Australia
      • +1 more
      Dec 17, 2013

      Non-Hodgkin Lymphoma Trial in Worldwide (doxycycline (tetracycline))

      Completed
      • Non-Hodgkin Lymphoma
      • doxycycline (tetracycline)
      • Providencia, Santiago, Chile
      • +5 more
      Nov 22, 2013

      Lymphoma Trial in Cleveland (biological, drug, procedure, radiation)

      Completed
      • Lymphoma
      • filgrastim
      • +6 more
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
      Oct 28, 2013

      Leukemia, Lymphoma, MDS Trial in Cleveland (drug, radiation, procedure)

      Completed
      • Leukemia
      • +3 more
      • Cleveland, Ohio
        Case Medical Center, University Hospitals Seidman Cancer Center,
      Jun 19, 2013

      Lymphoma, Small Intestine Cancer, Solid Tumor Trial in San Antonio (ixabepilone)

      Completed
      • Lymphoma
      • +2 more
      • San Antonio, Texas
      • +2 more
      Feb 8, 2013

      DLBCL Trial in Gent (VELCADE, Rituximab, Cyclophosphamide)

      Completed
      • Diffuse Large B-Cell Lymphoma
      • Gent, Belgium
        Universitair Ziekenhuis Gent - UZ GENT, Hematologie, 9K12IE 9de
      Dec 11, 2013

      Expression of Glycine/ Serine Pathway Molecules in Solid Tumors

      Unknown status
      • Solid Tumor Cancer
        • Singapore, Singapore
          Nationa University Hospital
        Apr 1, 2014

        Drug/Agent Toxicity by Tissue/Organ, Lymphoma, Neutropenia Trial in Chicago (cyclosporine, irinotecan HCl, phenobarbital)

        Completed
        • Drug/Agent Toxicity by Tissue/Organ
        • +4 more
        • Chicago, Illinois
          University of Chicago Cancer Research Center
        Feb 4, 2013

        Lymphoma of Mucosa-Associated Lymphoid Tissue Trial in Austria (Rituximab, 2-CdA)

        Completed
        • Lymphoma of Mucosa-Associated Lymphoid Tissue
        • Graz, Austria
        • +4 more
        Dec 23, 2013

        Lymphoma Trial in United States (romidepsin)

        Completed
        • Lymphoma
        • Washington, District of Columbia
        • +3 more
        Feb 8, 2013

        MALT Lymphoma Trial (Bortezomib (Velcade))

        Completed
        • MALT Lymphoma
        • Bortezomib (Velcade)
        • (no location specified)
        Nov 26, 2013

        Lymphoma Trial in United States (bexarotene, methoxsalen, UV light therapy)

        Unknown status
        • Lymphoma
        • Birmingham, Alabama
        • +18 more
        Dec 17, 2013

        Lymphoma Trial in United States (filgrastim, rituximab, carboplatin)

        Terminated
        • Lymphoma
        • filgrastim
        • +4 more
        • Mobile, Alabama
        • +84 more
        Apr 8, 2013